INGEN Valuation

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>IT</div>
IGNT -- USA Stock  

USD 0.0001  0.0001  50.00%

What would the acquisition value of INGEN TECHNOLOGIES INC be today? INGEN TECHNOLOGIES seems to be undervalued based on Macroaxis valuation methodology. Our model calculates the value of INGEN TECHNOLOGIES INC from examining the firm fundamentals such as return on asset of (2.02) %, current valuation of 5.84 M, and price to sales of 2.33 X as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we encourage acquiring undervalued assets and selling overvalued assets since, in the future, asset prices and their ongoing real values will come together.

Search Valuation

 
Refresh
INGEN TECHNOLOGIES Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as INGEN TECHNOLOGIES's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
0.0001
13th of July 2020
0.00012302
Real Value
38.38
Upside
INGEN TECHNOLOGIES is out of control asset. Calculation of real value of INGEN TECHNOLOGIES INC is based on 3 months time horizon. Increasing INGEN TECHNOLOGIES INC time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.000111110.000111110.00011111
Details
Hype
Prediction
LowEstimated ValueHigh
0.000.0000841338.38
Details
Naive
Forecast
LowNext ValueHigh
0.0000020.00009638.38
Details

INGEN TECHNOLOGIES Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining INGEN TECHNOLOGIES's current stock value. Our valuation model uses many indicators to compare INGEN TECHNOLOGIES value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across INGEN TECHNOLOGIES competition to find correlations between indicators driving INGEN TECHNOLOGIES's intrinsic value. More Info.
INGEN TECHNOLOGIES INC is rated below average in price to sales category among related companies. It is currently regarded as number one stock in beta category among related companies totaling about  0.92  of Beta per Price to Sales. The ratio of Price to Sales to Beta for INGEN TECHNOLOGIES INC is roughly  1.09 

About INGEN TECHNOLOGIES Valuation

The Macroaxis Equity Valuation Mechanism determines the current worth of INGEN TECHNOLOGIES INC on a weekly bases. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of INGEN TECHNOLOGIES INC. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of INGEN TECHNOLOGIES INC based exclusively on its fundamental and basic technical indicators. By analyzing INGEN TECHNOLOGIES's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of INGEN TECHNOLOGIES's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of INGEN TECHNOLOGIES. We calculate exposure to INGEN TECHNOLOGIES's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to INGEN TECHNOLOGIES's related companies.
Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California. INGEN TECHNOLOGIES operates under Medical Devices classification in the United States and is traded on BATS Exchange.

INGEN TECHNOLOGIES Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as INGEN TECHNOLOGIES does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Revenue Growth-56.90%
Enterprise Value To Revenue430.29
Please see Risk vs Return Analysis. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page